Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives

Itakura, Go, Kawabata, Soya, Ando, Miki, Nishiyama, Yuichiro, Sugai, Keiko, Ozaki, Masahiro, Iida, Tsuyoshi, Ookubo, Toshiki +11 more·2017·Stem Cell Reports
DOI 10.1016/j.stemcr.2017.02.003

Cited by (115)

Items 101–115 of 115

  1. The progress in the study of reprogramming to acquire the features of stem cells in iPSCs and cancers
    Shigeo Saito, Kenly Wuputra, Kohsuke Kato, Kazunari K. Yokoyama · 2021 · Elsevier eBooks
  2. Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk
    Sanne Hillenius, Joaquin Montilla‐Rojo, Thomas F. Eleveld, Daniela C. F. Salvatori, Leendert H. J. Looijenga · 2023 · Springer eBooks
  3. Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps
    Jae-Woo Jung, Je Hoon Jeong, Myeong Jin Ko, Byung‐Jou Lee, Woo‐Keun Kwon, Sang Ryong Jeon, Subum Lee · 2024 · Korean Journal of Neurotrauma
  4. Considerations on chemistry, manufacturing, and control of stem cell products for Investigational New Drug application in China
    Jiaqi Lü, Wei Wei · 2020 · Biologicals
  5. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells
    Takamasa Hirai, Ken Kono, Rumi Sawada, Takuya Kuroda, Satoshi Yasuda, Satoko Matsuyama, Akifumi Matsuyama, Naoya Koizumi, Naoki Utoguchi, Hiroyuki Mizuguchi et al. · 2021 · Scientific Reports
  6. Exploring hiPSC-CM replacement therapy in ischemic hearts
    Giuseppe Cipriano, Thomas Thum, Natalie Weber · 2025 · Basic Research in Cardiology
  7. Functional Recovery by Transplantation of Human iPSC-Derived A2B5 Positive Neural Progenitor Cell After Spinal Cord Injury in Mice
    Yiyan Zheng, Xiaohui Chen, Ping Bu, Haipeng Xue, Dong Kim, Hongxia Zhou, Xu‐Gang Xia, Ying Liu, Qilin Cao · 2025 · International Journal of Molecular Sciences
  8. Generation and Differentiation of Induced Pluripotent Stem Cells from Mononuclear Cells in An Age-Related Macular Degeneration Patient.
    Tongmiao Wang, Jingwen Liu, Jianhua Chen, Bo Qin · 2022 · PubMed Central
  9. Human embryonic stem cells (hESC) as a source of insulin-producing cells
    Sara Dutton Sackett, Daniel M. Tremmel, Austin K. Feeney, Samantha A. Mitchell, Jon S. Odorico · 2019 · Elsevier eBooks
  10. Pluripotent stem cell biology and engineering
    João P. Cotovio, Tiago G. Fernandes, Maria Margarida Diogo, Joaquim M. S. Cabral · 2019 · Elsevier eBooks
  11. The therapeutic potential of exogenous adult stem cells for the injured central nervous system
    Jayden A. Smith, Alice Braga, Regan Hamel, Carola Rutigliani, Bryan Yu, Luca Peruzzotti‐Jametti, Stefano Pluchino · 2020 · Elsevier eBooks
  12. Microfluidic Chip for Label-Free Removal of Teratoma-forming Cells from Therapeutic Human Stem Cells
    Kyle Wellmerling, Christian Lehmann, Ankur Singh, Brian J. Kirby · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  13. Reprogramming of Cells by Lactic Acid Bacteria
    Naofumi Ito, Kunimasa Ohta · 2018 · Springer eBooks
  14. Les cellules souches pluripotentes dans le traitement de l’insuffisance cardiaque
    Manon Desgres, Philippe Menasché · 2019 · médecine/sciences
  15. Genetic Safety Switches for Pluripotent Stem Cell-Derived Therapies for Diabetes
    Dena E. Cohen, Jon S. Odorico · 2023 · Springer eBooks